The effect of anticholinergic agents-atropine, propantheline, oxyphencyclimine, and propionyl atropine methyl nitrate-on saliva flow and on hypoglycaemic stimulated gastric secretion has been studied. The acid secretion of the nervous phase of gastric secretion was inhibited by anticholinergic drugs. They influenced gastric secretion to a greater extent than saliva flow.
Anticholinergic drugs are widely used in the treatment of peptic ulcer and with this aim new preparations are constantly being produced. One of the advantages over atropine claimed for the newer preparations is that they produce fewer side-effects, which implies that they have a selective action on the stomach. Apart from one French study (Lieber, 1956 ) that showed that the more recently developed preparations were inferior to atropine in this respect, there is no work in man, supported by the quantitative determination of their effect on gastric secretion and of their side-effects, comparing atropine with the newer anticholinergic agents.
Because of the importance of whether or not the newer drugs have a selective action on the stomach, the present study was undertaken. Atropine and three new preparations (propantheline, oxyphencyclimine, and propionyl atropine methyl nitrate) were compared as regards their effect on saliva flow and on hypoglycaemic stimulated gastric secretion.
METHOD
For several reasons it was not possible to determine both responses in the same group of patients. Consequently one group of volunteers was studied as regards saliva flow and a second group as regards gastric secretion; the results were then analysed statistically.
Saliva flow was stimulated by chewing. Gum devoid of the outer flavoured coat was used; the gum was chewed for 10 minutes and the volume of saliva secreted measured.
Three control readings were taken and subsequently readings at hourly intervals after the administration of the drug until saliva flow returned to normal. Side-effects, particularly the presence of a dry mouth, blurred vision, or difficulty in micturition were noted. The volunteers used in this study were members of the resident medical staff; seven such studies were made.
The effect on gastric secretion was determined using hypoglycaemic stimulated secretion. For this, patients having insulin coma therapy for psychiatric reasons were used. After fasting, the drug was given between 6.30 a.m. and 6.45 a.m. followed by a large dose of insulin (the dosage ranged between 200 and 1,600 units). The patient went into coma two to two and a half hours after the administration of insulin and spent one hour in coma. Coma was considered to be present when the patient no longer responded to painful stimuli and extensor plantar responses were present. It had previously been determined that under these conditions control studies gave reproducible responses. Gastric secretion was determined during 30 minutes of the hour spent in coma, using continuous suction with a Cleland tube. Each patient had from one to four, usually two, control studies done; the control studies and the studies after the drugs were randomized. Eight patients were studied. Patients who showed more than a trace of bile in the gastric juice were not included in the series.
The acid concentration was estimated using phenol red as an indicator. The drugs administered were atropine sulphate gr. 1/100, propantheline 30 mg., oxyphencyclimine 10 mg., and propionyl atropine methyl nitrate 18 mg.; all were given orally.
RESULTS
EFFECT ON SALIVA FLOW The effect on saliva flow during the four hours after the administration of the drugs is given in Table I . The saliva flow is expressed The ± figure is the S.E. of the mean.
as a percentage of the mean of the control readings. Table II gives the effect of the drugs on saliva flow three hours after the administration of the drugs, and Table III lists the severity of side-effects as judged subjectively at this time interval by the seven subjects studied; it is seen that there is a correlation TAB It is seen from Table I that the maximal action is reached during the second hour. At two hours there is no significant difference in potency of the above doses of atropine, propantheline, and oxyphencyclimine but a significant difference between these three drugs and propionyl atropine methyl nitrate (P = 0-01); and at three hours there is no significant difference between atropine, propantheline, and oxyphencyclimine, or between propantheline and propionyl atropine methyl nitrate; there is a significant difference between oxyphencyclimine and propionyl atropine methyl nitrate (P = 0 02), and between atropine and propionyl atropine methyl nitrate (P = 0.05).
THE EFFECT ON GASTRIC SECRETION The effect of the series of anticholinergic drugs on hypoglycaemic stimulated secretion is given in Table IV . This effect was usually determined two and a half to three hours after the administration of the drug. The response is expressed as a percentage of the mean control output.
In Table V drug's effect, either on saliva flow or gastric secretion, is only compared in those individuals who actually had both drugs, thus removing the factor of variation between individuals. It is seen that though there was no significant difference between the effect of atropine and either oxyphencyclimine or propantheline as regards their effect on saliva flow, both propantheline and oxyphencyclimine had a significantly greater effect than atropine on gastric secretion. Hence it appears from this analysis that two of the newer preparations studied have a selective action on the stomach when compared with atropine.
In the previous analysis the drugs were compared as regards their relative potency only in those patients who had received both drugs. If we assume that both groups, those who were studied as regards saliva flow and those studied as regards gastric secretion, were analogous groups we can compare statistically the effect of the two drugs on saliva flow and gastric secretion. From their modes of selection, this is a reasonable assumption as both groups were physically healthy men in the 18 to 35 age groups. It is seen (Table VI) that atropine, propantheline, and oxyphencyclimine had a significantly more marked effect on gastric secretion than on saliva flow, this preponderant effect on gastric secretion being least in the case of atropine and most marked in the case of propantheline, with oxyphencyclimine in an intermediate position. A measure of this degree of selectivity is given by the ratio comparing their effect on gastric secretion with their effect on saliva flow (Table VI) The relative effect of propantheline and oxyphencyclimine deserves further mention. It is seen from Tables II and IV that when compared three hours after administration, in the dosage used, oxyphencyclimine had, in six of the seven cases studied, a more marked effect on saliva flow, whereas when their comparative effect on gastric secretion is studied, oxyphencyclimine had less inhibitory effect on gastric secretion than propantheline in five cases, and an equivalent effect in one case. When the two preparations are compared as in Table V it is seen that 30 mg. of propantheline had a more marked effect on gastric secretion than 10 mg. of oxyphencyclimine, whereas the latter had a more marked effect on saliva flow than 30 mg. of propantheline; neither of these differences were significant at the 5 % level, however. It must be realized in such a comparison as this that we are-comparing two drugs (Piper, Elliott, Sietsma, and Pryor, 1960) . It was noted that when two 15-minute specimens were taken, two and a half to three hours after propantheline, the second was usually greater than the first, whereas after oxyphencyclimine both specimens tended to be equal.
DISCUSSION
One would expect the most accurate method to use to assess the action of anticholinergic drugs on gastric secretion would be the investigation of their effect on vagally stimulated secretion. If one surveys, however, the recorded work on the effect of anticholinergic drugs on hypoglycaemic stimulated secretion, it is found that many workers have found that the acid output is unaffected (Bayer and Bradford, 1952; Bayer, Plummer, and Bradford, 1952; Levin, Kirsner, and Palmer, 1952; Winkelstein, 1952; Roback and Beal, 1953; Weisiger, Burke, and Plummer, 1954; McKenna, Smith, and Wyse, 1954; Kasich, Boleman, and Rafsky, 1956; Bachrach, 1958) . Others, nevertheless, have observed an inhibitory effect (Lieber, 1956; Plummer, Burke, and Bradford, 1951; Rock and Rohrer, 1958) and our own observations support these findings (Piper, Elliott, Sietsma, and Pryor, 1960) . The failure to observe a drop after anticholinergic drugs by some workers appears to have been due to inadequate dosage of the drug and the inability to make repeated observations on the same patient. We found, using the method outlined, control readings with a coefficient of variation of 3.7 % could be obtained in those patients secreting more than 3 ml. of gastric juice per minute and in all patients a diminution of acid output could be produced by most anticholinergic drugs. Those drugs that produced no effect were considered not to have been given in adequate dosage.
One of the main problems involved in the clinical use of anticholinergic agents has been the determination of the extent to which they are superior to atropine. Assessment of drugs that produce sideeffects by the use of clinical trials in diseases with the variable course for which they are commonly used is fraught with many difficulties. The only previous similar study comparing quantitatively the therapeutic effect and side-effects of a similar series of drugs was made by Lieber (1956) . He studied hypoglycaemic stimulated secretion and found that atropine was superior to propantheline and oxyphenonium when the effect of a given dose on gastric secretion and on the intensity of side-effects was compared. The detailed investigation of Kirsner, Levin, and Palmer (1953) on the relation of sideeffects to the inhibition of basal secretion showed that no drug consistently reduced gastric secretion without side-effects. Rock and Rohrer (1958) compared the effect of propantheline, 30 mg., and atropine, 1 mg., on insulin-stimulated gastric secretion and found that both significantly reduced acid output but, though the output after propantheline was less marked than after atropine, the difference was not significantly different. The present study has shown that though the four drugs investigated, including atropine, reduced the nervous phase of gastric secretion more readily than they did saliva flow, only propantheline and oxyphencyclimine had a selective action on the stomach superior to atropine, these differences being statistically significant.
Oxyphencyclimine was first studied pharmacologically by Finkelstein, P'an, Niesler, Johnson, and Schneider (1959) ; they found it to be in animals a powerful anticholinergic agent, with a marked effect on the stomach and a prolonged duration of action. A subsequent study of its effect on saliva flow and gastric secretion by Piper et al. (1960) confirmed its prolonged action in humans. The present investigation showed that it has a more selective action on the stomach than atropine but that it is not as selective two and a half hours after its administration as propantheline. Its chief advantage appears to be its prolonged action which is almost twice as long as that of propantheline (Piper et al., 1960) ; thereby night secretion can be controlled and, with three doses during the day, a constant inhibitory effect can be obtained. However, if the length of action is of no importance, it appears that propantheline is superior to oxyphencyclimine because of its more selective action on the stomach.
Propionyl atropine methyl nitrate is a quaternary ammonium ester of atropine and was considered by Herman, Shaw, and Rosenblum (1958) after animal experiments to be worthy of clinical trial. Subsequently, Herman and Shaw (1958) showed that it reduced the volume and acidity of the gastric secretory response to an alcohol test meal and slowed gastric motility as measured by the rate of glucose absorption. Both these methods can be criticised as methods of assessment of an anticholinergic agent because the response to a meal is partially under chemical and partially under vagal control (Woodward, Lyon, Landor, and Dragstedt, 1954) and there is no evidence to show that there is a correlation between anticholinergic-induced hypomotility and sucrose absorption. Giving doses of Banthine that inhibited bowel motility, as shown by balloon observations, and produced marked side-effects, Cummins and Almy (1953) found that the adsorption of glucose was not affected. The maximum dose recommended by the manufacturers is three tablets, with one tablet as the usual dose. It would appear from the findings of the present study that this maximum dose is relatively ineffective in inhibiting gastric secretion; as an antisecretory agent it is inferior to propantheline and oxyphencyclimine and not superior to atropine.
In the final assessment of the place of any anticholinergic preparation, many factors must be considered. Its effect should be determined by pharmacological studies and confirmed, if possible, by clinical trial. It should have a selective action on the diseased organ, have a prolonged duration of action, and be low in cost. The present study demonstrated that the nervous phase of secretion can be significantly depressed and oxyphencyclimine and propantheline have a selective action on the stomach when compared with atropine. Despite their selective action some side-effects should be present; the present study confirmed the great variation in the individual responses to anticholinergic agents shown by others (Sun and Shay, 1956) and it is only by the presence of minimal side-effects that one can be sure that an effective dose is being administered.
From the above data, it is seen that the selectivity of any drug can only be considered in a relative sense. In this study different methods of stimulation of the two secretions were used and the selectivity of the drugs must be evaluated remembering this fact. Chewing, used in this study to stimulate saliva flow, is a common stimulant of saliva secretion in ordinary circumstances, and the effect in this response may reasonably be considered a suitable index to use to determine the frequency and severity of the common side-effect of anticholinergic drugs, namely, a dry mouth. It was shown too, that there was good correlation between all subjective side-effects and the degree of inhibition of saliva secretion (Tables II  and III) .
Finally, this investigation has confirmed the fact that drugs do vary in the degree of selectivity of their action on the stomach. It is possible therefore that a drug may yet be manufactured that produces a complete medical vagotomy, which implies complete inhibition of the vagal phase of gastric secretion with the absence of generalized effects of parasympathetic block.
